FAIM
QUAL icon

Financial Advocates Investment Management’s iShares MSCI USA Quality Factor ETF QUAL Stock Holding History

Financial Advocates Investment Management’s Portfolio QUAL Stock Details QUAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.34M Sell
12,028
-100,274
-89% -$18.8M 1.32% 27
2025
Q2 		$20.5M Buy
112,302
+14,679
+15% +$2.53M 1.67% 9
2025
Q1 		$16.7M Buy
97,623
+4,162
+4% +$745K 1.17% 14
2024
Q4 		$16.6M Sell
93,461
-2,275
-2% -$413K 0.95% 18
2024
Q3 		$15.9M Buy
95,736
+12,035
+14% +$2.09M 0.9% 16
2024
Q2 		$14.3M Buy
83,701
+10,190
+14% +$1.67M 0.89% 17
2024
Q1 		$11.7M Buy
73,511
+4,333
+6% +$677K 0.68% 26
2023
Q4 		$9.97M Buy
69,178
+3,024
+5% +$419K 0.65% 28
2023
Q3 		$8.54M Sell
66,154
-11,380
-15% -$1.55M 0.61% 31
2023
Q2 		$10.5M Sell
77,534
-1,430
-2% -$182K 0.75% 22
2023
Q1 		$9.8M Buy
78,964
+17,414
+28% +$2.09M 0.7% 24
2022
Q4 		$7.01M Buy
61,550
+7,506
+14% +$851K 0.52% 40
2022
Q3 		$5.45M Buy
54,044
+13,565
+34% +$1.59M 0.45% 49
2022
Q2 		$4.52M Buy
40,479
+1,429
+4% +$174K 0.37% 71
2022
Q1 		$5.26M Buy
39,050
+5,874
+18% +$780K 0.35% 69
2021
Q4 		$4.83M Buy
33,176
+4,790
+17% +$677K 0.3% 76
2021
Q3 		$3.74M Buy
28,386
+5,523
+24% +$759K 0.25% 105
2021
Q2 		$3.04M Buy
22,863
+2,807
+14% +$360K 0.2% 126
2021
Q1 		$2.44M Sell
20,056
-232
-1% -$27.4K 0.17% 133
2020
Q4 		$2.25M Buy
20,288
+4,816
+31% +$530K 0.15% 149
2020
Q3 		$1.6M Sell
15,472
-13,638
-47% -$1.4M 0.14% 164
2020
Q2 		$2.79M Buy
29,110
+510
+2% +$46.8K 0.26% 97
2020
Q1 		$2.32M Buy
28,600
+18,414
+181% +$1.76M 0.33% 76
2019
Q4 		$1.03M Buy
+10,186
New +$981K 0.11% 206
2018
Q1 		– Sell
-15,945
Closed -$1.32M – 525
2017
Q4 		$1.32M Buy
+15,945
New +$1.29M 0.18% 122

Other funds holding QUAL

Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Financial Advocates Investment Management's QUAL Position: Q3 2025 in Review

Financial Advocates Investment Management reduced its iShares MSCI USA Quality Factor ETF (QUAL) stake by 89% in Q3 2025, selling an estimated $18.8M and leaving 12,028 shares worth $2.34M. The position accounts for 1.32% of the portfolio, ranked #27.

Financial Advocates Investment Management first reported a position in QUAL in Q4 2017 and has held it in 25 quarters since. The position peaked at $20.5M in Q2 2025. 1,515 funds tracked by Wall St. Rank hold QUAL as of Q3 2025.

  • Financial Advocates Investment Management held 12,028 shares of iShares MSCI USA Quality Factor ETF worth $2.34M as of Q3 2025.
  • Financial Advocates Investment Management sold 100,274 iShares MSCI USA Quality Factor ETF shares in Q3 2025, an estimated $18.8M.
  • iShares MSCI USA Quality Factor ETF made up 1.32% of Financial Advocates Investment Management's portfolio in Q3 2025, its #27 holding.
  • Financial Advocates Investment Management first reported a position in iShares MSCI USA Quality Factor ETF in Q4 2017 and has held it in 25 quarters since.
  • Financial Advocates Investment Management's iShares MSCI USA Quality Factor ETF position peaked at $20.5M in Q2 2025.
  • 1,515 funds tracked by Wall St. Rank held iShares MSCI USA Quality Factor ETF as of Q3 2025.

Based on Financial Advocates Investment Management's 13F filing for Q3 2025, filed 6 Nov 2025.